ACTA Summit 2018

Events Overview

The ACTA Summit 2018 is precisely focussed on investigator-initiated, clinician-led clinical trials’ sector opportunities, challenges and expansion.

The Summit features an inspirationally relevant program – tier-one national keynote speakers, including Australian Government representatives, leading clinician researchers, and our wider stakeholder community.

You will be networking and sharing knowledge with delegates from across the Australian and New Zealand clinical trials sectors, including ACTA’s MRFF-supported Reference and Special Interest Groups presenting and gathering feedback on their 2017-2020 program of work to support, strengthen and grow the clinical trials sector.

The Summit directly follows the 7th Annual NHMRC Symposium on Research Translation: Ensuring Value in Research at the same venue.

Register now

Summit program – draft

Wednesday 28 November 2018

4:30 pm – 5:30 pm – Annual General Meeting (AGM)

5:30 pm – 7:00 pm Advisory Council Meeting

(Closed session subject to separate booking; details will be sent to members.)

Thursday 29 November 2018

8:30 am – 9:00 am – Registration

9:00 am – 10:30 am – Welcome and Plenary
Prof John Zalcberg
Our better health through best evidence future
Chair, ACTA

Ms Glenys Beauchamp
Secretary, Australian Government Department of Health

Prof Cliff Hughes
President, International Society for Quality in Healthcare

Dr Tony Penna
Developing an accreditation standard for research governance approval
Director, NSW Office for Health and Medical Research

10:30 am – 11:00 am – Morning tea

11:00 am – 1:00 pm – Session 2
A/Prof Katie Groom
Developing best practice guidance for clinical trial network operations
Liggins Institute, University of Auckland 

Prof Rachelle Buchbinder
Monash University, ANZMUSC CTN– Australia and New Zealand Musculoskeletal Clinical Trials Network

Prof Alan Cass
Challenges and successes in ATSI clinical research
Menzies School of Health Research

Prof Anushka Patel
Australian New Zealand Alliance for Cardiovascular Trials (ANZACT) Network
George Institute
CTN Sector Expansion ACTA Reference Group (B)

Panel discussion
A/Prof Katie Groom, Prof Rachelle Buchbinder, Prof Alan Cass, Prof Anushka Patel, Mr Toby Richards
Chair: Prof Steve Webb

1:00 pm – 2:00 pm – Lunch

2:00 pm – 3:30 pm – Session 3
Prof Jonathan Morris
Keys to successful clinical trial embedding
IMPACT Network

Prof Sally Green
Optimising implementation
Co Director, Cochrane Australia
Graduate Research Coordinator, Public Health and Preventive Medicine, Monash University
Impact and Implementation of CTN Trials ACTA Reference Group (C)

Dr Christopher Williams
Embedding Clinical Trials in Healthcare (D)
NHMRC Research Fellow

Panel discussion
Prof Jonathan Morris, Prof Sally Green, Dr Christopher Williams

3:30 pm – 4:00 pm – Afternoon tea

4:00 pm – 4:30 pm – Session 4
Prof Steve Wesselingh
ACTA and AHRA: Cross Pollination bearing fruit

Executive Director and Infection and Immunity Theme Leader, South Australian Health and Medical Research Institute

4:30 pm – 5:30 pm
Prof Hans Lund & A/Prof Jennifer Yost
Aspects of consumer involvement in identifying and prioritising new research questions

Centre for Evidence-based Practice, Western Norway University of Applied Sciences /
M. Louise Fitzpatrick College of Nursing

Question and answer session
Prof Hands Lund & A/Prof Jennifer Yost

5:30 – Networking and canapes

Friday 30 November 2018

8:00 am – 8:50 am – Breakfast meetings

ACTA Registries breakfast meeting

Consumer Engagement (Reference Group E) breakfast meeting

9:00 am – 10:30 am – Session 5
Anne McKenzie AM
Strengthening Consumer Engagement in Developing, Conducting and Reporting Clinical Trials ACTA Reference Group (E)
Head, Consumer and Community Health Research Network

A/Prof Alison Tong
Stakeholder engagement in research priority setting
Sydney School of Public Health

Update from representative of Research Prioritisation: Tools and Criteria ACTA Reference Group (F)

Panel discussion

Prof Stephen McDonald
Clinical Quality Registries – national policy direction?

Executive Officer, ANZDATA Registry

11:00 am – 11:30 am – Morning tea

11:30 am – 1:00 pm – Session 6
A/Prof Mustafa Khasraw
Platform trial design in oncology 
Clinical Lead, NHMRC CTC
Sydney Medical School
Innovative Trial Design ACTA Reference Group (G)

Prof Madeleine King
eProms: Implementation in trials locally and internationally

Cancer Australia Chair in Cancer Quality of Life; School of Psychology and Sydney Medical School, University of Sydney
Innovation Outcome Data ACTA Reference Group (H)

Panel Discussion

1:00 pm – 1:30 pm 
Our thanks and our better health through best evidence future – plenary Summit wrap-up and Q&A and International Symposium preview
Prof John Zalcberg

Chair, ACTA

1:30 pm – 2:30 pm – Lunch

2:30 pm – 4:00 pm – Session 7: ACTA Reference and Special Interest Group-specific meetings
Research Prioritisation ACTA Reference Group (F) – closed session

The "How to?" and methodology behind innovative clinical trials
Innovative Trial Design and Conduct ACTA Reference Group (G) and STInG

ACTA Network Manager Special Interest Group

Embedding Clinical Trials in Healthcare ACTA Reference Group D – closed session

Register now